Menu

Experience

Nicola Maguire

    • Immunocore $312.1 Million Aggregate Financing 


    • Cooley Advises CEPI on its Partnership with VBI Vaccines Inc., to Develop VBI’s Vaccine Candidates Against Covid-19 Variants 


    • Immunocore – $297 Million IPO 


    • Genesis MedTech Acquires Drug Device Asset From TriReme Medical 


    • UNION Therapeutics Enters Licensing Option Agreement with TFF Pharmaceuticals 


    • Bavarian Nordic Acquires Two Commercial Vaccines from GlaxoSmithKline for €796 Million 


    • Mission Therapeutics Enters Collaboration Agreement with AbbVie 


    • Cooley Advises F-star on Collaborative Agreement with Denali Therapeutics 


    • Bristol Meyers Enters Agreement with Five Prime 


    • Immunocore Limited Series A $320 Million Financing 


    • Cooley Advises Immunocore on Largest European Private Life Sciences Financing on Record 


    • King's College Collaboration and Licence Agreement with UCB 


    • Meda: Rottapharm l Madaus Acquisition  


    • Wellcome Trust Collaboration and Option Agreement with Jansen and University of Leuven 


    • Karolinska Development Joint Venture with Rosetta Capital